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At least two antimicrobial systems exist in polymorphonuclear leukocytes
(PMN),' one that depends on the production of reactive oxygen intermediates
and another that is independent of the respiratory burst (1-3) . Neutrophil-
derived proteins have been implicated as components of the respiratory burst-
independent microbicidal pathway (4-6) . However, their nature, subcellular
localization, mode of action, and actual contribution to killing in vivo are still a
matter of debate . We have examined the location of bactericidal factors (BF) in
human neutrophils, taking advantage of a new method for the efficient subcel-
lular fractionation of these cells : disruption by nitrogen cavitation and centrif-
ugation of the postnuclear supernatant on a discontinuous Percoll density gra-
dient (7). In contrast to previous work, we have looked at the distribution of BF
at each step of the fractionation procedure and in all the fractions, from whole
cell lysates to isolated cellular compartments . On the basis of our localization
results, wehave used a highly purified organelle population, azurophilic granules,
as our starting material for the isolation of azurophil-derived bactericidal factors
(ADBF) .
Materials and Methods
Isolation ofNeutrophils.
￿
Blood was obtained from healthy donors who gave informed
consent . The blood was anticoagulated with 25 mM sodium citrate and mixed with an
equal volume of6% dextran in 0.9% NaCl to enhance the sedimentation of erythrocytes .
After 60 min at room temperature, the leukocyte-rich supernatant was collected and
centrifuged at 200g for 10 min . The cell pellets were resuspended in 0.9% NaCl . PMN
were separated from mononuclear cells by centrifugation through Ficoll-Hypaque and
contaminating erythrocytes removed by two successive cycles of hypotonic lysis, as de-
scribed (7, 8) . >98% of the cells were PMN, of which >95% were neutrophils and <3%
were eosinophils . We will refer to this preparation as neutrophils . One unit of blood
yielded 109 neutrophils .
Subcellular Fractionation ofNeutrophils.
￿
Isolated neutrophils in PBS (2 x 10 7 cells/ml)
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were treated with 5 mM DIFP for 15 min at 4°C. The DIFP-treated cells were centrifuged
at 130 g for 10 min at 4 ° C, and the pellet was resuspended in ice-cold relaxation buffer
containing 100 mM KCI, 3 mM NaCl, 1 mM ATP(Na)2, 3.5 mM MgCl2, 10 mM Pipes,
pH 7.3 . The cell suspension was disrupted by nitrogen cavitation for 20 min at 350 psi,
in a bomb (Parr Instrument Co., Moline, IL) at 4°C and the cavitate was collected into
EGTA, pH 7 .4 at a final concentration of 1 .5 mM. Nuclei and unbroken cells were
pelleted (P,) by centrifugation at 500 g for 10 min at 4°C. The postnuclear supernatant
(S,) was centrifuged for 15 min at 20,000 rpm (SS 34 rotor; Sorvall Instruments, Newtown,
CT) on a discontinuous Percoll density gradient, as described by Borregaard et al. (7).
Fractions of -1 ml were collected at 4°C and assayed for specific markers of azuro-
philic granules ((3-glucuronidase and myeloperoxidase), specific granules (vitamin B,2-
binding protein), and plasma membrane (alkaline phosphatase) as described below. Percoll
was removed from pooled fractions by centrifugation at 35,000 rpm (180,000 g) for 2 h
in an SW41 rotor (Beckman Instruments, Palo Alto, CA). The layer that sedimented
above the packed Percoll was resuspended in relaxation buffer, and stored in aliquots at
-70°C.
Assaysfor Specific Markers in Subcellular Fractions.
￿
To ensure complete solubilization,
aliquots from each fraction were diluted 1 :5 in Triton X-100 (0.05% wt/vol final
concentration) before enzyme or protein assays. Alkaline phosphatase was assayed with 1
mg/ml p-nitrophenyl phosphate as substrate in a 0 .3 MM MgC12, 50 mM sodium barbital
buffer, pH 10.5 . 50-AI samples diluted in Triton X-100 were assayed. Samples were
incubated for 80 min at 37°C in the assay mixture (1-ml vol) and the reaction was
terminated by addition of 100 Al of 1 N NaOH . The absorbance at 410 nm was read
immediately. The enzyme activity was calculated as described (9).
O-Glucuronidase was assayed by liberation of phenolphthalein from 1 mM phenol-
phthalein fl-monoglucuronic acid in 100 mM sodium acetate buffer, pH 4.4, at 37°C for
3 h . 25-,ul samples diluted in Triton X-100 were assayed in 550 Al of assay mixture. The
reaction was terminated by adding 200 jl of 1 M glycine, 1 M NaCl, and 1 M NaOH,
and the absorbance was read at 550 nm. The enzyme activity was calculated as described
(7).
Vitamin B,2-binding protein was measured on 25-, 50-, and 100-I1 samples diluted in
Triton X-100 essentially as described by Gottlieb et al. (10). [57Co]vitamin B,2 was prepared
by mixing 5 ng/ml vitamin B,2 (Sigma Chemical Co., St. Louis, MO) with 0.025 ACi/ml
["Co]cyanocobalamin (Amersham Corp., Arlington Heights, IL; sp. act. 105 cpm/ng).
750 Al of saline was mixed with 350 Al of ["Co]vitamin B,2 and with 100 Al of the final
volume of the sample. 0 .5 ml of albumin-coated charcoal was then added and the test
tubes were centrifuged for 2 min at 10,000 g at room temperature. I ml of the supernatant
was collected and counted in a Packard auto-gamma scintillation counter (Packard
Instrument Co., Downers Grove, IL) to determine the amount of bound [5'Co]vitamin
B,2 in each sample.
Protein was determined as described by Lowry et al. (11) using BSA as standard. To
prevent Triton X-100 interference with the assay, 0.1% SDS was added to the alkaline
copper solution (12). Percoll at the concentration present in the fractions did not affect
the assay.
To assay myeloperoxidase, 200 Al of each fraction was diluted fivefold in relaxation
buffer containing 0.2% Triton X-100, and introduced into the sample compartment of a
Perkin-Elmer 557 double-beam spectrophotometer (Coleman Instruments Div., Perkin-
Elmer Corp., Oak Brook, IL). Absorption spectra, from 400 to 600 nm, of oxidized
fractions versus fractions reduced with dithionite were then measured (E9,2 =
75/mM - cm) (13).
Preparation of ADBF.
￿
Fractions from the Percoll gradients corresponding to azuro-
philic granules were pooled and Percoll was removed by centrifugation as described (7).
The azurophilic granule preparation was resuspended in relaxation buffer and stored
either on ice at 4°C or at -70°C. The azurophilic granules stored on ice at 4°C appeared
to be intact in that no ,0-glucuronidase or myeloperoxidase release from the granules
could be detected for 2 wk. Freezing of the azurophilic granules at -70°C resulted in
some leakage (<<-20%) of the,6-glucuronidase but not of the myeloperoxidase. The isolatedGABAY ET AL.
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azurophilic granules were extracted with 0 .05 M glycine-HCI buffer, pH 2.0, for 40 min
at 25 ° C. The acid extract was centrifuged at 10,000 g for 20 min and the supernatant
used as a source of ADBF. The supernatant was either diluted in or dialyzed against the
incubation medium prior to bactericidal assays. For the dialysis of ADBF extracts, a
membrane tubing of 1,000 Mr cutoff (Spectra/Por, Spectrum Medical, Los Angeles, CA)
was used. Fractions from the Percoll density gradients were extracted by following the
same procedure; Percoll had no effect on the extraction or activity of bactericidal factor(s) .
Bactericidal Assays.
￿
Bactericidal activity was tested against Escherichia coli K12 (MC
4100) in routine assays and, where indicated, against Salmonella typhimurium LT2 (gifts
of Dr. H . Shuman, Columbia University), Pseudomonas aeruginosa PAC and PAO (gift of
Dr. A. Prince, Columbia University), Listeria monocytogenes (gift of Dr. R. Steinman, The
Rockefeller University), Staphylococcus aureus (gift of Dr. S. Blander, The Rockefeller
University), and Streptococcus pneumoniae type 111, type II, and an unencapsulated variant
ofthe S. pneumoniae type II strain (gifts of Dr. E. Tuomanen, The Rockefeller University).
Trypticase soy broth and trypticase soy agar plates were used to cultivate most bacteria.
In the case of S. pneumoniae, Cy medium and 5% defibrinated sheep blood agar plates
were used (14).
Organisms from a single colony on agar plates were inoculated into liquid medium and
cultured overnight at 37°C. Aliquots of the overnight culture were inoculated into fresh
nutrient broth and grown to the midexponential phase. Bacterial cultures were then
diluted into the test medium to the appropriate concentration. Most experiments were
performed in 0.05 M citrate buffer, pH 5.5 . Control experiments showed that this buffer
did not affect the viability of any of the bacteria tested except P. aeruginosa and S.
pneumoniae type 11, for which 0 .05 M phosphate buffer, pH 6.0, was used. Other buffers
such as acetate, phosphate, or citrate-phosphate at a concentration of 0.01 or 0 .05 M
were used in some bactericidal assays, as specified in the text.
Bacteria (4 x 10' CFU in a final volume of 200 j1) were incubated for 30 min at 37°C
with indicated amounts of azurophilic granule extract diluted in the incubation medium.
Samples were then diluted 1 :100 in M63 minimal medium (15), and spread onto agar
plates. CFU were counted after incubation at 37°C for 16 h. Bactericidal activity was
expressed as the percentage of bacteria killed after exposure to ADBF compared with
control . Alternatively, we defined 1 unit of killing activity (killing units, KU) as the
reciprocal of the number of micrograms per milliliter of protein necessary to kill 105
bacteria/ml in 30 min at 37'C (LD50).
Isolation of Azurophil Granule Membranes.
￿
Isolated azurophilic granules in relaxation
buffer (pH 7 .3) were disrupted by seven cycles of freezing in an acetone/dry ice bath and
thawing at 37°C followed each time by immersion for 30 s in a sonicating water bath
(Branson B3, Heat Systems-Ultrasonics Inc., Plainview, NY). A pelleted material was then
obtained by centrifugation of the lysed granules at 10,000 g for 60 min or at 135,000 g
for 6 min at 4° C . We refer to this pelleted material as azurophilic granule membrane.
Isolated granule membranes and soluble granule contents were assayed for ADBF activity
after incubation with 0.05 M glycine, pH 2.0, as previously described.
Results
Subcellular Distribution of BF.
￿
To determine the subcellular location of BF,
we fractionated the neutrophils, using the method of Borregaard et al. (7).
Neutrophils were treated with 5 mM DIFP before fractionation because DIFP,
a potent serine protease inhibitor, has been shown to inhibit proteolysis very
effectively in PMN extracts (16, 17) . 109 DIFP-treated cells were disrupted by
nitrogen cavitation, and the postnuclear supernatant was centrifuged on a dis-
continuous Percoll density gradient. Each fraction of the gradient was assayed
for specific markers of azurophilic granules (myeloperoxidase), specific granules
(vitamin B 12-binding protein) and plasma membrane (alkaline phosphatase). As
shown in Fig. 1, the method resulted in efficient separation of these three1410
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FIGURE 1.
￿
Subcellular distribution of bactericidal activity in human neutrophils. (A) Distri-
bution ofmarkersfor(")azurophilic granules (myeloperoxidase), (A)specific granules (vitamin
B,2-binding protein [B12-BP], and (") plasma membrane (alkaline phosphatase). (B) Profile
of bactericidal activity. Each fraction was extracted with 0.05 M glycine-HCI, pH 2.0, and
centrifuged at 10,000 g for 20 min, and the supernatant was incubatedwith E. coli K12, at a
protein concentration of 5 Ag/ml. The percentage of bacteria killed after 30 min incubation
at 37°C is presentedhere. Inset(C)showstheamount ofprotein from (_*_)purified azurophils
and (-A-) purified specific granules necessary to produce 50% reduction in bacterial CFU
(LD5o).
compartments. Azurophilic granules showed no contamination by markers of
specific granules or plasma membranes. Specific granules were not contaminated
by plasma membranes but had some contamination by azurophilic granules, as
indicated by the presence of 10% of the myeloperoxidase in this peak.
Bactericidal activity, obtained by extraction of cellular fractions at pH 2.0,
distributed as shown in Table 1. The majority of activity of the cavitate was
present in the postnuclear supernatant (SI). 6% of activity was associated with
the nuclear fraction, perhaps because of adherence of a few granules to nuclei .
The location of BF in the granule fraction was further indicated by a specific100
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TABLE I
Distribution ofBF in Human Neutrophils
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FIGURE 2.
￿
Membrane association ofADBF. Isolated azurophilic granules in relaxation buffer
(pH 7.3) were disrupted by freeze-thaw/sonication and centrifuged. The supernatant (/), the
pelleted material (0), and the total granules (,L) were extracted at pH 2.0 and tested for
bactericidal activity.
activity that was twice that of the unfractionated cavitate. As shown in Fig. 1,
>90% of BF was present in the azurophilic granule fraction. The low level of
activity present in the specific granule fraction could be attributed to the 10%
contamination by azurophilic granules, as detected by myeloperoxidase assay (see
Fig. 1). Indeed, ^-10 times more protein from the specific than from the
azurophilic granule fraction was required to kill 50% of the bacteria (inset, Fig.
1) . These results strongly suggest that these BF are located exclusively in the
azurophilic granule of human neutrophils.
Membrane Association of BF.
￿
To determine the location of BF within azuro-
philic granules, we lysed the intact purified granules at neutral pH by repeated
freeze-thaw and sonication, centrifuged the disrupted granules, and separated
soluble granule contents from pelleted granule membranes. Under these condi-
tions, >90% of ,Q-glucuronidase and myeloperoxidase were found in the super-
natant fraction (data not shown). In contrast, 98% of ADBF was associated with
azurophil membrane, as shown in Fig. 2.
Purification step Volume
ml
Protein
mg/ml
KU
Sp act
(KU/mg
protein)
Yield
Cavitate 9.8 3 .0 2.5 0.8 100
Pellet 2 .0 3 .0 0.75 0.25 6
S,* 8.8 2.3 2 .75 1 .2 97
S2$ 8 .0 1 .3 0.025 0 .02 0 .8
y (plasma membrane) 3 .0 0.65 0.03 0.05 0.4
/3 (specific granules) 3.0 1 .05 0.38 0.36 4.5
a (azurophilic granules) 3 .0 1 .1 7 .0 6.4 86
* Postnuclear supernatant.
$ Cytosol.1412
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FIGURE 3.
￿
Effect of pH on the extraction of BF from azurophilic granule membranes.
Aliquots of azurophilmembraneswere added to various buffer systems (0.05 M): glycine, pH
2.0-3.0; citrate, pH 4.0-6.0; phosphate, pH 7.0. After incubation at 25 °C for 40 min, the
suspensions were centrifuged at 10,000 g for 20 min and the supernatants assayed for protein
contentandbactericidal activity. Killingunits(KU) correspond to thereciprocal ofthe number
of microgram permilliliter of protein necessary to kill 10 bacteria in 30 min at 37 °C. In each
case, the bactericidal assay was conducted in 0.05 M citrate buffer, pH 5.5 .
We next examined the ability of a number of agents to release ADBF from
azurophil membranes. ADBF activity was assayed in the supernatant and pellet
obtained after centrifugation of azurophil membranes treated with buffers of
varying pH . Fig. 3 shows that <10% of ADBF activity was released from the
membrane at pH 5.0-7 .0, 50% at pH 4.0, and all at pH 2.0-3 .0 . The extraction
of BF from intact azurophilic granules followed the same pH curve (data not
shown).
Other agents commonly used to solubilize peripheral and integral membrane
proteins were then tested (Table II). Treatment of the azurophil membranes
with 1 % Triton X-100 released ADBF activity as effectively as acid. In contrast,
neither 2 M NaCl, 6 M urea, nor 0.1 M sodium bicarbonate, pH 11, released
ADBF from the granule membrane .
Triton X-114 has been used on isolated membranes or whole cells to separate
integral membrane proteins from hydrophilic proteins; hydrophilic proteins are
recovered in the aqueous phase, whereas amphiphilic integral membrane proteins
are found in the detergent phase after the phase separation of this detergent at
?20°C (18, 19). When azurophil membranes were extracted with Triton X-114,
87% of ADBF activity partitioned with the detergent phase (Table II).
ADBF Activity In Vitro Depends on Releasefrom the Azurophil Membrane.
￿
We
sought to determine if ADBF is active when associated with the membrane or if
activity requires its release from the membrane. Azurophil membranes were
treated at pH 2.0, which solubilizes ADBF, or at pH 5.5, which represents
intralysosomal pH (20-22) but does not release ADBF from the membrane (Fig.
3). Bactericidal activity was then assayed at pH 5.5 in total membranes, and in
the supernatant and pellet fractions obtained after centrifugation of the mem-TABLE 11
Effect ofpH, Ionic Strength, and Surface-active Agents on the Release ofADBFfrom
the Azurophilic Membrane
GABAY ET AL.
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50 jiI of azurophil membranes (0.5 mg protein/ml) were incubatedat 25 °C for 40 min in 200 Al
of the various agents listed above. After centrifugation at 10,000 g for 20 min (4°C), the
supernatants were collected, dialyzed against 0.05 M citrate, pH 5.5, andtested forprotein content
and bactericidal activity. Pelletswere washed threetimes with ice-cold 0.05 M phosphate, pH 7.0,
incubatedat 25°C for 40 min with 0.05 M glycine, pH 2.0, and centrifuged, andthe supernatants
were assayed for protein and killing activity. For Triton X-114 treatmentof azurophil membranes,
we followed the procedure describedby Bordier (18).
* Aqueous phase.
Detergent phase.
§ Not applicable.
branes treated at both pH's. ADBF from membranes treated at pH 5.5 (mem-
brane-bound ADBF, 1 KU) was 10 times less active than ADBF from membranes
treated at pH 2.0 (soluble ADBF, 11 .6 KU). Bactericidal activity could be
recovered almost completely from membranes treated at pH 5.5 by reextraction
at pH 2.0 (Table 11).
Effect of Dose, Time, Bacterial Growth Status, and Buffer.
￿
ADBF activity was
linear with respect to protein concentration over the range of 0.3-30 wg/ml (Fig.
1 and further data not shown). The effect of bacterial concentration is shown in
Fig. 4. Up to 107 bacteria/ml could be killed by 30 ,tcg/ml of ADBF-containing
extract in 30 min at 37°C . Killing was rapid; 50% of the cells were killed within
5 min at 37'C by the azurophilic granule extract containing 1.4 Ag of protein/ml
(Fig. 5). The physiologic state of the bacteria incubated in the test medium did
not affect their susceptibility to ADBF. Thus, bacteria in exponential growth or
in a stationary phase were equally sensitive. The addition of glucose (20 mM) to
the incubation medium did not affect ADBF activity. The killing activity of
ADBF was approximately the same when citrate, acetate or phosphate salts were
used as a buffer (data not shown) .
Effect ofpH and Divalent Cations.
￿
Because it has been shown that phagosomes
rapidly reach and maintain a pH value of 5.5 during intracellular killing of
bacteria in vivo (20-22), we examined theeffect of pH on the bactericidal activity
of ADBF in vitro. ADBF was effective over a broad range of pH (5.0-8.0) (Fig.
Azurophil membranes
Buffer
treated with:
Additional agents
Bactericidal ac-
tivity of mate-
rial released
into superna-
tant
KU
Bactericidal ac-
tivity of mate-
rial remaining
in membrane
pellet
0.05 M glycine, pH 2.0 14.0 <0.1
0.05 M citrate, pH 5.5 0.2 11 .6
0.1 M sodium bicarbonate, pH <0.1 10.8
11 .0
0.05 M phosphate, pH 7.0 2 M NaCl <0.1 8.0
None 6 M urea <0.1 12.8
0.05 M phosphate, pH 7.0 1% Triton X-100 12.8 <0.1
0.01 M Tris, pH 7.4 0.15 M NaCl 1.7* NA$
0.5% Triton X-114 11 .31 NA1414
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FIGURE 4.
￿
Bactericidal activity of azurophilic granule extract on increasing concentrations
of bacteria. Granule extract was prepared as described in Materials and Methods. 30 ug/ml
(*), 3 wg/ml (A), 0.3 tog/ml (/), or 0.03tag/ml (A) of the azurophil extract was added foreach
bacterial concentration tested.
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FIGURE 5.
￿
Kinetics of bactericidal activity of ADBF. E. coli K12 (2 x 105 CFU/ml) was
incubated with 1.4,ug/ml (0)or 0.7 kg/ml (A) of azurophilic granuleextract in 0.05 M citrate
buffer, pH 5.5, andwith citrate buffer alone (/).
6), with an optimum at pH 5.5 . Media more acid than pH 5.0, which are
bactericidal per se, could not be used to test ADBF killing.
Because ions such as Mg" and Ca" play a critical role in phagocytic processes
(23) and also affect the surface properties of Gram-negative bacteria (24), we
examined the effect of these ions on ADBF bactericidal activity. Mgt+ ions
antagonized but did not completely block ADBF activity. The effect of Mgt+
ions was maximal at 1 mM, with a 25% reduction in bactericidal activity (data
not shown). In contrast, Ca
21 ions inhibited all ADBF activity at a concentration100
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FIGURE 6.
￿
Effect of pH on bactericidal activity of ADBF. E. coli (2.5 X 105 CFU/ml) was
incubated for 30 min at 37 °C with 2.8 jug/ml (0) or 0.7 wg/ml (A) of azurophilic granule
extract in citrate buffer, pH 5 and 5.5, and sodium phosphate or sodium phosphate-citrate
buffer, pH 6.0-8.0.
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FIGURE 7.
￿
Effect of Ca21 ions on ADBF activity. E. coli K12 (2.5 X 105 CFU/ml) was
incubated for 30 min at 37°Cwith 2.8 ,+g/ml of azurophilic granule extract in 0.05 M citrate
buffer, pH 5.5, supplemented with CaCl2 as shown.
of 25 mM (Fig. 7). The decrease of bactericidal activity was linear with respect
to calcium concentration over the range of 1-25 mM. In that the medium used
for these tests contains citrate, which chelates divalent cations, the concentration
of free cations in solution is lower than the nominal concentration . However,
citrate does not bind significant amounts of Mgt' and Ca2+ at low pH (25). The
addition of EDTA (1-25 mM) to the incubation medium, to chelate cations, did
not affect ADBF activity (data not shown). NaCl inhibited at concentrations of
?0.3 M(Fig. 8). Physiologic concentrations ofNaCl or KCl did not inhibit ADBF
activity, when the latter was tested at a concentration >>-2.8 ug/ml.141 6
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FIGURE 8.
￿
Effect of NaCl concentration on bactericidal activity ofADBF. E. coli K12 (2.5 X
105 CFU/ml) was incubated for 30 min at 37°C with 2.8 tug/ml (0) or 1.4 tag/ml (A) of
azurophilic granule extract in 0.05 M citrate buffer, pH 5.5, supplemented with NaCI as
shown. Arrow indicates NaCl concentration ofplasma.
TABLE III
Antibacterial Spectrum ofADBF
* ADBF activity is scored according to the micrograms per milliliter of
protein in azurophil extract necessary to kill 10 bacteria in 30 min at
37°C: +, 0.1-0.3 tug/ml; (+), 1-2.5 tug/ml; -, >20 tag/ml.
$Clinical isolates from two patients with toxic shock syndrome.
BacterialSpectrum ofADBF Killing.
￿
ADBF killsboth Gram-positive and Gram-
negative bacteria (Table 111). The Gram-positive bacteria susceptible to ADBF
killinginclude different strains ofStaphylococcus aureus (two isolated from patients
with toxic shock syndrome), a-hemolytic streptococci (with the exception of the
capsulated streptococcus type 111) and to some extent Listeria monocytogenes. All
the Gram-negative bacteria tested were killed as efficiently as E. coli.
Discussion
Since the early studies by Hirsch (26-28), various bactericidal proteins have
been described and in some cases isolated from neutrophils (6, 17, 29-33). The
Organism Strain or type ADBF
activity*
Staphylococcus aureus S27 +
Staphylococcus aureus 450 +
Staphylococcus aureus TSS-I$ +
Staphylococcus aureus TSS-2t +
Streptococcuspneumoniae Type III -
Streptococcus pneumoniae Type II +
Streptococcus pneumoniae R6 +
Listeria monocytogenes 450 (+)
Pseudomonas aeruginosa PAC +
Pseudomonas aeruginosa PAO 103-0 +
Salmonella typhimurium LT2 +
Escherichia coli K12 MC 4100 +GABAY ET AL.
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subcellular location of these or other human neutrophil-derived bactericidal
proteins has not been established. In this report, we treated human neutrophils
with DIFP to prevent proteolysis and fractionated them using a scheme that
results in clear separation of cytosol, plasma membrane, specific granules, and
azurophilic granules, with minimal proteolysis or alteration of granule integrity
and density. We then determined the optimum conditions for the extraction and
assay of bactericidal factors; BF were maximally extracted at pH 2.0-3.0 and
assayed at pH 5.5 (phagolysosomal pH). Under these conditions, we screened all
cellular compartments and found that most of the bactericidal activity (97%) was
associated with the postnuclear supernatant (S,) and ^-90% of the activity comi-
grated with the azurophilic granule population, after centrifugation of S, on
Percoll density gradients. Neither the cytosol nor the plasma membrane fractions
had significant activity. The low level of activity (5-10%) in the specific granule
fraction could be accounted for by the 5-10% contamination of this fraction by
myeloperoxidase-positive azurophil granules. Our data showed a single location
for human neutrophil BF, in the azurophilic granule.
In support of these results, a single location for BF was found in bovine
neutrophils, where bactericidal activity was exclusively localized to a large mye-
loperoxidase-negative granule population (34). In addition, a recent preliminary
report (35) indicated that one of the neutrophil-derived BFs (bactericidal perme-
ability-increasing protein) can be recovered (90%) in the cellular fractions
containing azurophilic granules. In contrast, Rest et al . (36) found BF in both
azurophilic and specific granules of human neutrophils. Because they used a
different technique of fractionation (homogenization in sucrose and isopycnic
centrifugation on sucrose density gradients), as well as different methods of
extraction and assay, their results are not directly comparable with ours.
ADBF was associated with the azurophil membrane. Upon lysis of azurophilic
granules at neutral pH, which solubilizes 90% of the myeloperoxidase, 98% of
ADBF remained in the membrane-containing pellet . All of the membrane-
associated ADBF could be extracted at pH 2.0 and released in soluble form after
centrifugation of the acid-treated membrane . Possible explanations for the
solubilizing effect of acid are: (a) acid induces a proteolytic event, (b) acid induces
conformational changes that disrupt the association of ADBF with the granule
membrane, or (c) acid displaces a charge interaction between ADBF and the
membrane. Low pH was not strictly required for solubilization of ADBF. Triton
X-100 at neutral pH could also release ADBF . Agents commonly used to
solubilize peripheral membrane proteins, such as 2 M NaCl, 6 M urea, or 0.1 M
sodium bicarbonate, pH 11, were unable to dissociate ADBF from the azurophil
membrane. This indicates that ADBF is either tightly associated with or an
integral constituent of the azurophil membrane. Indeed, upon treatment of
azurophil membrane with Triton X-114, ADBF behaved similarly to an integral
membrane constituent, in that it partitioned into the detergent phase.
We attempted to address the question of whether the release of BF from the
membrane is necessary for bactericidal activity. Membrane-bound ADBF was 10
times less active than soluble ADBF, suggesting a coupling in vitro between
ADBF solubilization and activity. The molecular mechanism of ADBF activation
in vivo is yet to be understood.1418
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On the basis of our localization results, we used intact, purified azurophil
granules as a source of BF and studied their properties. This contrasts to previous
work in which bactericidal proteins were obtained from an heterogeneous
granule-enriched fraction by extraction with acid over long periods of time (6,
17, 30), in the absence of protease inhibitor (6, 30). ADBF resembles some of
the bactericidal proteins previously described in being acid-extractable and
granule-associated. In particular, ADBF shares many of the characteristics of the
rabbit neutrophil-derived phagocytin (27, 28, 37): (a) Changes in the test medium
such as a variation in the buffer, the addition of glucose, and inclusion of a metal
binding agent had little effect on the bactericidal activity of ADBF. (b) Divalent
cations (Mg", Ca
2+) were not required for its lethal action. At high concentra-
tions, these ions antagonized or, in the case of Ca", inhibited completely the
bactericidal effect (ID50 for Cat+, 10 mM). (c) Like phagocytin, ADBF was more
active at a low pH (5 .0-5.5), the estimated phagolysosomal pH during intracel-
lular killing of bacteria.
ADBF differs from other reported neutrophil-derived antimicrobial proteins
in a number of ways. ADBF is active over a wide range of pH, with optimum
activity at pH 5.5, and is relatively insensitive to high ionic strength. This
contrasts with bactericidal permeability-increasing factor, which is optimally
active at pH 7.0, or defensins, which strictly require pH 7.0-8 .0 and low ionic
strength conditions for bactericidal activity (6, 30, 33, 34). By its antimicrobial
spectrum, ADBF differs from purified factors such as bactericidal permeability-
increasing factor or cationic antimicrobial proteins, which are only active on
Gram-negative bacteria (17, 30, 33).
ADBF is extremely active; 0.1-0.3 Mg/ml can kill 105 bacteria per ml, using a
wide range of test organisms-Gram-positive and Gram-negative bacteria. Pu-
rified BF specific for Gram-negative bacteria, such as bactericidal permeability-
increasing factor (30) and the 57 kD cationic antimicrobial protein (17) have
comparable activity, whereas others, such as defensins, seem to be active only at
higher concentrations (>50 mg/ml) on both Gram-positive and Gram-negative
bacteria (6, 33). In addition, ADBF kills bacteria rapidly; >50% killing is achieved
within 5 min.
Because ADBF is not a homogeneous preparation, its activity in the azurophil
membrane extract may be due to a single protein species or to the combined
activity of several proteins that act synergistically. ADBF killing does not appear
to involve H202-dependent systems, since catalase (500 U/ml) does not signifi-
cantly reduce its activity (data not shown) and since >90% myeloperoxidase is
released in the soluble fraction upon isolation of membrane ADBF. The azuro-
phil membrane is composed of a limited number of protein species, including
two major polypeptides of 29 and 6 kD (38). Further characterization and
purification of ADBF is needed to determine if it comprises a novel bactericidal
protein or proteins or if it includes some of the bactericidal proteins previously
described.
Summary
We examined the subcellular location of bactericidal factors (BF) in human
neutrophils, using an efficient fractionation scheme . Nitrogen bomb cavitates ofDIFP-treated PMN were centrifuged through discontinuous Percoll gradients,
each fraction extracted with 0.05 M glycine, pH 2.0, and tested for the killing
of Escherichia coli. >90% of BF coisolated with the azurophil granules. After lysis
of azurophils, 98% of azurophil-derived BF (ADBF) sedimented with the mem-
brane. ADBF activity was solubilized from azurophil membrane with either acid
or nonionic detergent (Triton X-100, Triton X-114). Bactericidal activity was
linear with respect to protein concentration over the range 0.3-30 tag/ml. 0.1-
0.3 wg/ml ADBF killed 10'E. coli within 30 min at 37°C. At 1 .4 Ag/ml, 50% of
2 x 105 bacteria were killed within 5 min. ADBF was effective between pH 5-
8, with peak activity at pH 5.5 . Glucose (20 mM), EDTA (1-25 mM), and
physiologic concentrations of NaCl or KCl had little or no inhibitory effect on
ADBF. ADBF killed both Gram-positive and Gram-negative virulent clinical
isolates, including listeria, staphylococci, (3-hemolytic streptococci, and Pseudo-
monas aeruginosa. Thus, under these conditions of cell disruption, fractionation,
extraction, and assay, almost all BF in human PMN appeared to be localized to
the membrane ofazurophilic granules as a highly potent, broad-spectrum, rapidly
acting protein(s) effective in physiologic medium. Some of these properties
appear to distinguish ADBF from previously described PMN bactericidal pro-
teins.
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